A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
Travera Inc
Eli Lilly and Company
Regor Pharmaceuticals Inc.
Bayer
Eastern Cooperative Oncology Group
International Agency for Research on Cancer
Arcus Biosciences, Inc.
Sotio Biotech Inc.
Radiopharm Theranostics, Ltd
Eli Lilly and Company
SystImmune Inc.
Terremoto Biosciences Inc.
Rondo Therapeutics
M.D. Anderson Cancer Center
Orano Med LLC
Wake Forest University Health Sciences
Ensem Therapeutics
Atavistik Bio, Inc
Merck Sharp & Dohme LLC
Ataturk University
Mayo Clinic
Alterome Therapeutics, Inc.
University College Cork
Convalife (Shanghai) Co., Ltd.
Eli Lilly and Company
ViroMissile, Inc.
Kaiser Permanente
AstraZeneca
Tizona Therapeutics, Inc
Normunity AccelCo, Inc.
New Phase Ltd.
Institute of Cancer Research, United Kingdom
University of Colorado, Denver
MacroGenics
Amgen
Institut Curie
SystImmune Inc.
University of Kansas Medical Center
Daiichi Sankyo
Adela, Inc
Eli Lilly and Company
Ocellaris Pharma, Inc.
Medical College of Wisconsin
Memorial Sloan Kettering Cancer Center
Fusion Pharmaceuticals Inc.
Innate Pharma